Lymphoma and Female Fertility

Embryo freezing is a medically accepted way to preserve the possibility of fertility. First, the ovaries are stimulated to mature multiple eggs. Doctors remove the mature eggs and fertilize them in the lab with sperm from a partner or donor to create embryos. The fertilization process is called in vitro fertilization (IVF). Embryos are then frozen for future use. The steps required to freeze embryos take between two and six weeks.



Egg freezing is an option for women who may not have a male partner or who are not ready to choose a sperm donor. There is a new research that indicates it may have potential for cancer patients.



“Everything we’ve heard before about egg freezing needs to be put away,” said Dr. Geoffrey Sher, Executive Medical Director of ReproCure and the Sher Institutes for Reproductive Medicine. “Up until now, existing technology only offered a 1%-to-4% baby rate per frozen egg….a false promise of success,” noted Dr. Sher. “But ECT and vitrification, dual processes that allow us to select only chromosomally normal eggs for safe cryobanking are paradigm shifters. They give women a realistic fertility preservation alternative they can count on.”

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap